The future of artemisinins: Natural, synthetic or recombinant?

Journal of Biology

Volumn 7, Issue 10, 2008, Pages

  Hommel, Marcel ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTESUNATE; COARSUCAM; DIHYDROARTEMISININ; ENDOPEROXIDE; HEMOZOIN; QUININE; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT;

ANTIMALARIAL ACTIVITY; CHEMICAL MODIFICATION; DRUG COST; DRUG EFFICACY; DRUG MANUFACTURE; DRUG MECHANISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG SYNTHESIS; DRUG UTILIZATION; ESCHERICHIA COLI; EXTRACTION; FUNDING; GAMETOCYTE; GENETIC ENGINEERING; HUMAN; MALARIA FALCIPARUM; MONOTHERAPY; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION; SACCHAROMYCES CEREVISIAE; SCHISTOSOMIASIS; SCIENTIFIC LITERATURE; SHORT SURVEY; CHEMISTRY; GENETICS; MALARIA; METABOLISM; REVIEW; YEAST;

ANTIMALARIALS; ARTEMISININS; GENETIC ENGINEERING; MALARIA; YEASTS;

EID: 65549102748     PISSN: None     EISSN: 14754924     Source Type: Journal    
DOI: 10.1186/jbiol101     Document Type: Short Survey

References (15)

1. World Heath Organization, Guidelines for the Treatment of Malaria WHO/HTM/MAL/2006.1108.
2. Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid. DK Ro M Ouellet EM Paradise H Burd D Eng CJ Paddon JD Newman JD Keasling, BMC Biotechnol 2008 8 83 18983675 10.1186/1472-6750-8-83
3. Second-generation antimalarial endoperoxides. SR Meshnick CW Jefford GH Posner MA Avery W Peters, Parasitol Today 1996 12 79 82 10.1016/0169-4758(96) 80660-0 15275260
4. Reaction of artemisinin with haemoglobin: implications for antimalarial activity. R Kannan K Kumar D Sahal K Kukreti VS Chauhan, Biochem J 2005 385 409 418 15361062 10.1042/BJ20041170
5. Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. K Stepniewska RN Price CJ Sutherland CJ Drakeley L von Seidlein F Nosten NJ White, Malar J 2008 7 249 10.1186/1475-2875-7-249 19055751
6. Qinghaosu: the price of success. NJ White, Science 2008 320 330 334 10.1126/science.1155165 18420924
7. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. A Dondorp F Nosten K Stepniewska N Day N White South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group, Lancet 2005 366 717 725 10.1016/S0140-6736(05)67176-0 16125588
8. Artemisinins: their growing importance in medicine. S Krishna L Bustamante RK Haynes HM Staines, Trends Pharmacol Sci 2008 29 520 527 10.1016/j.tips.2008.07.004 18752857
9. Estimating antimalarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs). JM Kindermans D Vandenbergh E Vreeke P Olliaro JP D'Altilia, Malar J 2007 6 91 17623092 10.1186/1475-2875-6-91
10. Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies. JM Cohen I Singh ME O'Brien, Malar J 2008 7 200 18831742 10.1186/1475-2875-7-200
11. Artemisia annua as a self-reliant treatment for malaria in developing countries. S De Ridder F van der Kooy R Verpoorte, J Ethnopharmacol 2008 120 302 314 10.1016/j.jep.2008.09.017 18977424
12. Ensuring sustained ACT production and reliable artemisinin supply. JM Kindermans J Pilloy P Olliaro M Gomes, Malar J 2007 6 125 17868471 10.1186/1475-2875-6-125
13. Identification of an antimalarial synthetic trioxolane drug development candidate. JL Vennerstrom S Arbe-Barnes R Brun SA Charman FC Chiu J Chollet Y Dong A Dorn D Hunziker H Matile K McIntosh M Padmanilayam TJ Santo C Scheurer B Scorneaux Y Tang H Urwyler S Wittlin WN Charman, Nature 2004 430 900 904 10.1038/nature02779 15318224
14. Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. F Benoit-Vical J Lelièvre A Berry C Deymier O Dechy-Cabaret J Cazelles C Loup A Robert JF Magnaval B Meunier, Antimicrob Agents Chemother 2007 51 1463 1472 17242150 10.1128/AAC.00967-06
15. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. DK Ro EM Paradise M Ouellet KJ Fisher KL Newman JM Ndungu KA Ho RA Eachus TS Ham J Kirby MC Chang ST Withers Y Shiba R Sarpong JD Keasling, Nature 2006 440 940 943 10.1038/nature04640 16612385